Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive

Authors not listed

Huashan Hospital · 2021

Abstract

Alzheimer's disease (AD) is closely related to diabetes (DM). DM will aggravate the progression of AD, but the specific mechanism has not yet been clarified. Previous study found that a key pathological feature of the pancreas in patients with DM is islet amyloid polypeptide, and there is also islet amyloid polypeptide in the brain. Therefore, DM may cause cytotoxicity through the interaction between pancreatic amyloid and brain Aβ protein and further aggravate AD progress. In this study, starting with DM and AD pathological biomarkers, the amyloid PET target molecular probe 18F-AV45 will be used to monitor the dynamic changes of amyloid protein in the brain and pancreas during the development of AD. The completion of this study will provide a new view for understanding the mechanism of DM on AD cognitive dysfunction and effectively preventing and treating these two diseases.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-10 MST

Cite this

APA
Anonymous. (2021). The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive. <em>Huashan Hospital</em>. https://clinicaltrials.gov/study/NCT05372458
Vancouver
Anonymous. The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive. Huashan Hospital. 2021.
BibTeX
@misc{anon2021TheMec, title = {The Mechanism Study of Diabetic Pancreatic Amyloid Deposition on Cognitive}, author = {Anonymous}, journal = {Huashan Hospital}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings